These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21459576)

  • 21. Binuclear metal centers in plant purple acid phosphatases: Fe-Mn in sweet potato and Fe-Zn in soybean.
    Schenk G; Ge Y; Carrington LE; Wynne CJ; Searle IR; Carroll BJ; Hamilton S; de Jersey J
    Arch Biochem Biophys; 1999 Oct; 370(2):183-9. PubMed ID: 10510276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel competitive class of α-glucosidase inhibitors: (E)-1-phenyl-3-(4-styrylphenyl)urea derivatives.
    Kim JY; Lee JW; Kim YS; Lee Y; Ryu YB; Kim S; Ryu HW; Curtis-Long MJ; Lee KW; Lee WS; Park KH
    Chembiochem; 2010 Oct; 11(15):2125-31. PubMed ID: 20827790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.
    Cushman M; Sambaiah T; Jin G; Illarionov B; Fischer M; Bacher A
    J Org Chem; 2004 Feb; 69(3):601-12. PubMed ID: 14750781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors.
    Belyaev A; Zhang X; Augustyns K; Lambeir AM; De Meester I; Vedernikova I; Scharpé S; Haemers A
    J Med Chem; 1999 Mar; 42(6):1041-52. PubMed ID: 10090787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glycosylphosphatidylinositol-anchored phosphatase from Spirodela oligorrhiza is a purple acid phosphatase.
    Nakazato H; Okamoto T; Nishikoori M; Washio K; Morita N; Haraguchi K; Thompson GA; Okuyama H
    Plant Physiol; 1998 Nov; 118(3):1015-20. PubMed ID: 9808746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors.
    Tulsi NS; Downey AM; Cairo CW
    Bioorg Med Chem; 2010 Dec; 18(24):8679-86. PubMed ID: 21055952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of novel purple acid phosphatase inhibitors.
    Hussein WM; Feder D; Schenk G; Guddat LW; McGeary RP
    Medchemcomm; 2019 Jan; 10(1):61-71. PubMed ID: 30774855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
    Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
    Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases.
    Lassaux P; Hamel M; Gulea M; Delbrück H; Mercuri PS; Horsfall L; Dehareng D; Kupper M; Frère JM; Hoffmann K; Galleni M; Bebrone C
    J Med Chem; 2010 Jul; 53(13):4862-76. PubMed ID: 20527888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-function relationships of purple acid phosphatase from red kidney beans based on heterologously expressed mutants.
    Truong NT; Naseri JI; Vogel A; Rompel A; Krebs B
    Arch Biochem Biophys; 2005 Aug; 440(1):38-45. PubMed ID: 16009331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of a purple acid phosphatase, representing different steps of this enzyme's catalytic cycle.
    Schenk G; Elliott TW; Leung E; Carrington LE; Mitić N; Gahan LR; Guddat LW
    BMC Struct Biol; 2008 Jan; 8():6. PubMed ID: 18234116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Fe(III)Zn(II) form of recombinant human purple acid phosphatase is not activated by proteolysis.
    Funhoff EG; Bollen M; Averill BA
    J Inorg Biochem; 2005 Feb; 99(2):521-9. PubMed ID: 15621285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Binding Mode of an ADP Analogue to a Metallohydrolase Mimics the Likely Transition State.
    Feder D; Gahan LR; McGeary RP; Guddat LW; Schenk G
    Chembiochem; 2019 Jun; 20(12):1536-1540. PubMed ID: 30719821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of a mammalian purple acid phosphatase.
    Uppenberg J; Lindqvist F; Svensson C; Ek-Rylander B; Andersson G
    J Mol Biol; 1999 Jul; 290(1):201-11. PubMed ID: 10388567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electronic structure and spectro-structural correlations of Fe(III)Zn(II) biomimetics for purple acid phosphatases: relevance to DNA cleavage and cytotoxic activity.
    Peralta RA; Bortoluzzi AJ; de Souza B; Jovito R; Xavier FR; Couto RA; Casellato A; Nome F; Dick A; Gahan LR; Schenk G; Hanson GR; de Paula FC; Pereira-Maia EC; de P Machado S; Severino PC; Pich C; Bortolotto T; Terenzi H; Castellano EE; Neves A; Riley MJ
    Inorg Chem; 2010 Dec; 49(24):11421-38. PubMed ID: 21080710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Farnesyl-derived inhibitors of ras farnesyl transferase.
    Kang MS; Stemerick DM; Zwolshen JH; Harry BS; Sunkara PS; Harrison BL
    Biochem Biophys Res Commun; 1995 Dec; 217(1):245-9. PubMed ID: 8526918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.
    Sun WS; Park YS; Yoo J; Park KD; Kim SH; Kim JH; Park HJ
    J Med Chem; 2003 Dec; 46(26):5619-27. PubMed ID: 14667216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.